Showing results (71-80 of 208) with videos related to
Sort By:
Pageof 21
Kidney International|September 19, 2008
A rat model of chronic kidney disease-mineral bone disorderSharon M Moe, Neal X Chen, Mark F Seifert, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2019
Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBDNeal X Chen, Shruthi Srinivasan, Kalisha O'Neill, et al.Nephrology (Carlton, Vic.)|July 1, 2009
Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right?Miriam P Zidehsarai, Sharon M MoeAmerican Journal of Nephrology|October 11, 2003
Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus productSharon M Moe, Tilman B DrüekeSeminars in Dialysis|August 4, 2005
The role of vitamin D in vascular calcification in chronic kidney diseaseGodwin O Wolisi, Sharon M MoeClinical Journal of the American Society of Nephrology : CJASN|July 28, 2012
Calcium builds strong bones, and more is better--correct? Well, maybe notSophie A Jamal, Sharon M MoeClinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
The case against calcium-based phosphate bindersSharon M Moe, Glenn M ChertowAdvances in Chronic Kidney Disease|January 4, 2007
Management of chronic kidney disease mineral-bone disorderStephen Z Fadem, Sharon M MoeKidney International|June 27, 2013
Recent advances in the noninvasive diagnosis of renal osteodystrophyRanjani N Moorthi, Sharon M MoeClinical Journal of the American Society of Nephrology : CJASN|October 6, 2012
The case for routine parathyroid hormone monitoringStuart M Sprague, Sharon M MoePageof 21